Announced details
Medical care, routine clinical practice, medical information searches, preparation of medical records, preparation of referral letters and discharge summaries, medical institution operations
medimo has been adopted by approximately 3,000 medical institutions nationwide. Collabo ID is used by more than 490,000 healthcare and care workers.
株式会社medimo is a consolidated subsidiary of Suzuken. The service is provided through the Suzuken Group.
Free, subject to a usage limit. Free use is available up to 30 times per week. The service may become chargeable in the future.
The company does not address Contract Value / Impact on Business Performance.
medimo’s in-house survey (9–16 September 2026; 11 respondents; in-app survey)
| Item | Details |
|---|---|
| Names of Products / Services Covered | medimo AI Chat, medimo |
| Relationship with the Company | 株式会社medimo is a consolidated subsidiary of Suzuken. The service is provided through the Suzuken Group. |
| Offering price | Free, subject to a usage limit. Free use is available up to 30 times per week. The service may become chargeable in the future. |
| Launch date | Launched on 12 November 2026 (actual). Available from 14 October 2026 at medical institutions under contract with medimo. |
| Applicable area | Medical care, routine clinical practice, medical information searches, preparation of medical records, preparation of referral letters and discharge summaries, medical institution operations |
| Usage history | medimo has been adopted by approximately 3,000 medical institutions nationwide. Collabo ID is used by more than 490,000 healthcare and care workers. |
| Source | medimo’s in-house survey (9–16 September 2026; 11 respondents; in-app survey) |
Items this document does not state (11)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.General-purpose generative AI often fails to adequately show the basis for its answers or its information sources, raising concerns about reliability in medical settings, while demand was growing for rapid access to reliable medical information and materials specific to individual medical institutions.